Arun J. Sanyal
@ArunJSanyalVCU
Followers
891
Following
433
Media
56
Statuses
394
The views expressed here do not necessarily reflect those of VCU, its medical school or the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health.
RVA liver lover since 1989.
Joined August 2023
Thanks to AJMC for covering this research on using NITs to track treatment response in semaglutide #MASH trial. #livertwitter
https://t.co/dSzUVmreqd
ajmc.com
A wide range of non-invasive tests reliably reflected semaglutide-related improvements in metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis.
0
1
4
Can we use NLP #AI to ⬆️objectivity of #Hepaticencephalopathy diagnosis? Yes! 3 cohorts (@RichmondVAMC @VCU_Liver #NACSELD) showed 5 phrases w ⬆️value Implications for 🔑 #Transplant priority 🔑 remote adjudication of clinical trials https://t.co/EmXhJ5GFqD
@AmJGastro
1
13
42
Appreciated the opportunity to share some thoughts in these videos on 2 of the presentations delivered at #TLM2025, focused on the clinical relevance of the ELF test in #MASLD. https://t.co/xorzJp0Iu6
#livertwitter #liverhealth #liver
medicalaffairs.siemens-healthineers.com
This page features a three-part video series from a leading hepatology expert, including an introductory teaser highlighting their collaboration with SHS and two scientific presentations based on...
0
2
17
AASLD President elect @saulkarpen inaugurating the PG course at #TLM2025: A Lifetime of Liver Health 👶🏻 → 👴🏻 Check out team @VCU_Liver at TLM 👉 https://t.co/BcCPMbHoD0 Excited to engage, learn and collaborate! 🤩 @AASLDtweets @AASLDPresident @AASLDFoundation
0
7
58
Liver health is essential for brain health! Prof @JasmohanBajaj discussing about liver disease as a contributor to dementia 😶🌫️ at #TLM2025 PG course 10-13% of patients being treated as dementia could have HE 🧠 HE is reversible 🔄 dementia is not ❌ Multidisciplinary approach
1
9
48
Have you ever wondered if a disease-agnostic agent could slow down progression of cirrhosis? 📉 💊 From beta-blockers ⬇️ portal pressure to albumin stabilizing hemodynamics 🌊 🦠 rifaximin reshaping the gut-liver axis, and statins tackling inflammation Check out our 📖
1
19
103
MASLD affects 🧠, 🫀, and other organs! Prof. @ArunJSanyalVCU highlighting that liver is the upstream driver for various end-organ effects 🔗 at #TLM2025 PG course. MASLD+obesity in 👶🏻 linked to ⬆️ DM Poor pregnancy outcomes 🤰🏻in pts with MASLD AHA-PREVENT calculator to assess
0
10
46
GLP-1RA are superior to Bariatric surgery for MALO and mortality reduction 👍 @VCU_Liver post-doc @kavin_parmar, did a great job presenting our work at #TLM2025
@ArunJSanyalVCU
@AASLDtweets @AASLDFoundation @AASLDPresident @EASLedu @EASLnews @AmCollegeGastro @AmerGastroAssn
2
4
39
Very proud of this team!
0
0
19
Join us on Oct. 22, at 5 p.m., to hear Anna Mae Diehl, M.D., of Duke University, talk about “Fixing Fatty Livers.” Register at https://t.co/J0rlEA2UGF
#liver #duke #livertwitter @Duke_GI_
0
2
3
Thrilled that our new outpatient clinic is opening to help the many in Richmond, Virginia, the U.S., and the world with liver disease and metabolic health issues. #livertwitter
@VCU_liver and @VCUHealth today debuted a new multidisciplinary outpatient clinic for liver and metabolic health patients. The Liver and Metabolic Health Outpatient Clinic is expected to serve 3,000 new liver patients for VCU Health in its first year. https://t.co/thRdTHtfWT
0
2
19
Very kind of you. @jasmohanbajaj and I appreciated the opportunity to be there for the occasion.
Thank you for accepting our invitation sir. It was lovely to have you all here. Look forward to meeting you at @AASLDtweets TLM @VCU_Liver @ArunJSanyalVCU @gvraoaig
0
2
19
I appreciate the invitation.
Thank you to @ArunJSanyalVCU for an insightful discussion at our #MASLD #MASH symposium at #OMASummit25! Your expertise brought real-world impact to this conversation. Missed it? Catch the replay here: https://t.co/bbyY7j63Cd
@OMASocial #CME #MedEd
0
2
17
Honouring the next generation of hepatology innovators. Congratulations to all the winners for their outstanding research, pushing the boundaries of science, shaping patient care, and inspiring the future of liver medicine. #AIGLiverConclave #LiverHealth #AIGHospitals
1
2
22
Packed room in the kick off day of the Latin American Association for the Study of the Liver (ALEH) meeting in Lima Peru today. Looking forward to a great educational and scientific activity. @alehlatam ;@juanpabloarab;@LuisAntonioDiaz;
2
6
41
All about Liver in 2025 only @ AIG Liver Conclave . Signature speaker series by @ArunJSanyalVCU Prof Angeli Prof Kamath and Prof Reddy AIG liver conclave nearing 1k registrations. @RoyAHep @ebtapper @sonalasthana @MajaThiele @JasmohanBajaj @VCU_Liver @JunedKh47457225
Our Signature Speaker Series at the AIG Liver Conclave 2025! Join us for insightful sessions with leading experts: - D Nageshwar Reddy, India on "AI and Innovations in Hepatology" - Patrick Kamath, USA on "Evolution of MELD: Role in Nontransplant Setting" - Arun Sanyal, USA
1
10
35
(1/3) ✨Exciting news in liver health: the FDA has accepted Echosens’ Letter of Intent to qualify LSM by VCTE (FibroScan®) as the first non-invasive surrogate endpoint in MASH clinical trials.
1
5
10
I'm very proud of what we've accomplished since 2022.
🔗: https://t.co/c0HWJ7KzE3 Linking research to patient care, @VCU_Liver creates innovative ways to tackle liver disease in Virginia and beyond.
3
2
24
Glad we now have a second option for our MASH patients.
🚨 Big milestone in MASLD/MASH! We now have two FDA-approved drugs: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) I made this simple side-by-side comparison 👇
1
9
33
W/ @juanpabloarab, "Public health policies to prevent alcohol-related liver disease"
@NatRevGastroHep Just ahead of my birthday, pleased to see two pieces in @NatRevGastroHep this month: On #public health policies to prevent alcohol-relater liver disease: https://t.co/J4KNhcOF1m And on expanding the MASLD community of practice: https://t.co/BTIOJmdLEu
#LiverTwitter #SLDthinktank
1
3
9